Skip to Main Content Published:October 13, 2020DOI:https://doi.org/10.1016/S2468-2667(20)30225-5 Log in Articles|Online First COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study Sarah Jefferies, MD Prof Nigel French, PhD Charlotte Gilkison, MPH Giles Graham, BSci…
Remdesivir Not Working So Far, Active Immunity vs. Passive Immunity
1,879 views •Oct 17, 2020 Dr Mobeen Sayed
Great Barrington Declaration
149,116 views •Oct 8, 2020 5.6K 1K Share Save Dr. John Campbell 776K subscriber
Learning from Japan
94,918 views •Oct 13, 2020 Dr. John Campbell 776K subscribers
Coronavirus Update 113: Remdesivir May Not Work for COVID 19
49,959 views •Oct 16, 2020
Studies show countries using Zinc & Hydroxychloroquine have far fewer COVID 19 deaths
Studies show countries using Zinc & Hydroxychloroquine have far fewer COVID 19 deaths 542 views •Aug 3, 2020
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality
Findings from the observational multicentre Italian CORIST study The COVID-19 RISK and Treatments (CORIST) Collaboration 1 Show footnotes Published:August 25, 2020DOI:https://doi.org/10.1016/j.ejim.2020.08.019 Abstract Background Hydroxychloroquine (HCQ) was proposed as potential treatment for COVID-19. Objective We set-up a multicenter Italian collaboration to…
Hydroxychloroquine Is Widely Used Around the Globe
August 19, 2020 Death rates in countries that rely on hydroxychloroquine (HCQ) for the treatment of COVID-19 appear to be dramatically lower than death rates in countries that discourage the use of the drug. A new study claims that the death rate in the…
Cuba: Early hydroxychloroquine potent against COVID-19
Cuba uses hydroxychloroquine and some other unique drugs in treatment of coronavirus, say Cuban medical authorities Vakkas Dogantekin |10.07.2020 Health authorities in Cuba are using low doses of the antimalarial drug hydroxychloroquine to effectively treat COVID-19 patients in the…
Hydroxychloroquine Should be Made Available, in a New Court Filing by the Association of American Physicians & Surgeons (AAPS)
TUCSON, Ariz., July 22, 2020 /PRNewswire/ — This week the Association of American Physicians & Surgeons submitted additional evidence to a federal court for why interference with hydroxychloroquine (HCQ) should end by the Food & Drug Administration (FDA) and the…
Early treatment with hydroxychloroquine: a country-based analysis
Covid Analysis, August 5, 2020 (updated October 10, 2020) @CovidAnalysis Share Tweet PDF Many countries either adopted or declined early treatment with HCQ, effectively forming a large trial with 1.8 billion people in the treatment group and 663 million in…
Dying in a Leadership Vacuum
s 1 Citing Article NEW ENGLAND JOURNAL OF MEDICINE October 8, 2020 N Engl J Med 2020; 383:1479-1480 DOI: 10.1056/NEJMe2029812 Chinese Translation 中文翻译 Covid-19 has created a crisis throughout the world. This crisis has produced a test of leadership.…
The Laboratory Origin of the Covid 19 Virus
Gain of Function Bioweapon Labs Get More NIH Funding for Deadly ‘Research’ EcoHealth Alliance collaborated with the Wuhan Institute of Virology for years, collecting coronavirus samples from bats and manipulating it to jump to humans The dangerous gain-of-function research…
The Cover Up of the Century
Zach Vorhies Google Inside Goes Public
Gain of Function Research
Gain of Function Research Mercola pdf Bioweapon Labs Get More NIH Funding for Deadly ‘Research’ **************************************************************************************************************************************************************************************************************************** Home Pandemic MimicNews Aug 19, 2020 – 03:40 227 0 “Gain-of-function” studies are, according to the U.S. Department Health and Human Services,1 research that involves…
In vitro inhibition of human influenza A virus replication by chloroquine
Chloroquine and Flue Virus 2006 study PDF Chloroquine is a 9-aminoquinolone with well-known anti-malarial effects. It has biochemical properties that could be applied to inhibit viral replication. We report here that chloroquine is able to inhibit influenza A virus…
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Virol J. 2005; 2: 69. Published online 2005 Aug 22. doi: 10.1186/1743-422X-2-69 PMCID: PMC1232869 PMID: 16115318 Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Martin J Vincent,1 Eric Bergeron,2 Suzanne Benjannet,2 Bobbie R Erickson,1 Pierre E Rollin,1 Thomas…
המלחמה בהידרוקסיכלורוקין יכולה להיות אחראית לגלעד
המלחמה בהידרוקסיכלורוקין יכולה להיות אחראית לגלעד, יצרנית התרופות המעוניינת להרוויח בגדול מרמדסביר. הידרוקסכלורוקין יעיל ובטוח לטיפול בקובד 19 ועשוי להיות יעיל באופן אוניברסלי בשימוש מוקדם לפני האשפוז: סקירה שיטתית חולים בדרום קרוליינה: אחד קיבל הידרוקסיקלורוקין, השני לא. 4 בספטמבר 2020…
Gilead’s War on Hydroxychloroquine
The Palmer Foundation Menu Home Videos Articles Press Releases Search Hydroxychloroquine is Effective and Safe for the Treatment of COVID-19, and may be Universally Effective When Used Early Before Hospitalization: A Systematic Review *************************************************************************************** Twin Covid-19 patients in South Carolina:…
